Rheumatology
Conference Coverage
Vitamin D and omega-3 supplements reduce autoimmune disease risk
“People who are otherwise healthy and have a family history of autoimmune disease might also consider starting to take these supplements.”
News
Better COVID-19 outcomes confirmed in TNF inhibitor users
A study of three international registries confirms that patients with immune-mediated inflammatory diseases who are taking a TNF inhibitor should...
News
Tramadol linked to higher risk of mortality, compared with codeine
Tramadol is widely used for noncancer pain but, as compared with codeine, it was associated with a higher risk for adverse outcomes, including...
News
Few JAK inhibitor users have diminished immune response to COVID-19 vaccines
Most patients taking JAK inhibitors had seemingly adequate immune responses based on serologic assessment of detectable antibodies, but those...
Conference Coverage
Better bone builder: High-intensity exercise vs. Pilates
A high-intensity resistance and impact training program improved bone heath and function; a low-intensity Pilates-based exercise program improved...
Conference Coverage
Exercise appears to improve bone structure, not density
In postmenopausal women, exercise appears to improve strength at the hip through changes in structure, not bone mineral density (BMD), whereas a...
News
Researchers describe first reports of breakthrough COVID infections, booster shots in rheumatology patients
The first published results of breakthrough SARS-CoV-2 infection in fully or partially vaccinated patients with RMDs hint at encouraging low rates...
News
NIH to study COVID vaccine booster in people with autoimmune disease
The trial will look at the impact of a booster in patients with five different autoimmune diseases who are either on or off immunosuppressives.
News
Tocilizumab shortage continues as pandemic wears on
Emergency use authorization of tocilizumab for COVID-19 has led to a global shortage, but supplies for rheumatoid arthritis and other inflammatory...
Conference Coverage
Physicians question the future of TNF inhibitors for psoriasis, PsA
Two dermatologists and two rheumatologists debate the merits of using IL-17 and IL-23 inhibitors ahead of TNF inhibitors for the treatment of...